CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Sinopharm Group Co. Ltd. - 1099 CFD

18.95
0.79%
Market Trading Hours* (UTC) Opens on Monday at 05:00

Mon - Fri: 01:30 - 04:00 05:00 - 08:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.15
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026116 %
Charges from full value of position ($-4.96)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026116%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.004199 %
Charges from full value of position ($0.80)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004199%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency HKD
Margin 5%
Stock exchange Hong Kong
Commission on trade 0%

*Information provided by Capital.com

Sinopharm Group Co Ltd ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 19.1
Open* 18.95
1-Year Change* 4.7%
Day's Range* 18.85 - 19.05
52 wk Range 16.98-28.45
Average Volume (10 days) 4.90M
Average Volume (3 months) 122.55M
Market Cap 61.66B
P/E Ratio 6.31
Shares Outstanding 3.12B
Revenue 646.40B
EPS 3.13
Dividend (Yield %) 4.55466
Beta 0.77
Next Earnings Date Mar 22, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 4, 2023 18.95 -0.20 -1.04% 19.15 19.30 18.85
Dec 1, 2023 19.10 0.10 0.53% 19.00 19.60 19.00
Nov 30, 2023 19.25 0.25 1.32% 19.00 19.80 18.65
Nov 29, 2023 18.90 -1.15 -5.74% 20.05 20.05 18.85
Nov 28, 2023 19.75 0.40 2.07% 19.35 19.80 19.15
Nov 27, 2023 19.35 -0.50 -2.52% 19.85 19.85 19.25
Nov 24, 2023 19.95 0.20 1.01% 19.75 20.05 19.60
Nov 23, 2023 19.90 0.10 0.51% 19.80 19.90 19.55
Nov 22, 2023 19.70 0.30 1.55% 19.40 19.80 19.40
Nov 21, 2023 19.45 -0.05 -0.26% 19.50 19.90 19.40
Nov 20, 2023 19.50 0.70 3.72% 18.80 19.50 18.70
Nov 17, 2023 18.70 -0.35 -1.84% 19.05 19.10 18.55
Nov 16, 2023 19.10 -0.45 -2.30% 19.55 19.60 18.90
Nov 15, 2023 19.60 -0.20 -1.01% 19.80 20.00 19.40
Nov 14, 2023 19.55 0.25 1.30% 19.30 19.65 19.20
Nov 13, 2023 19.30 0.10 0.52% 19.20 19.50 18.85
Nov 10, 2023 19.05 0.45 2.42% 18.60 19.25 18.60
Nov 9, 2023 19.05 -0.10 -0.52% 19.15 19.30 18.90
Nov 8, 2023 19.10 0.55 2.96% 18.55 19.25 18.55
Nov 7, 2023 18.75 -0.40 -2.09% 19.15 19.20 18.40

Sinopharm Group Co. Ltd. Events

Time (UTC) Country Event
Friday, March 22, 2024

Time (UTC)

10:59

Country

CN

Event

Full Year 2023 Sinopharm Group Co Ltd Earnings Release
Full Year 2023 Sinopharm Group Co Ltd Earnings Release

Forecast

-

Previous

-
Thursday, April 25, 2024

Time (UTC)

10:59

Country

CN

Event

Q1 2024 Sinopharm Group Co Ltd Earnings Release
Q1 2024 Sinopharm Group Co Ltd Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 552148 521051 456415 425273 344526
Revenue 552148 521051 456415 425273 344526
Cost of Revenue, Total 504714 477001 416091 387741 313298
Gross Profit 47434.1 44050.6 40323.3 37531.3 31228.1
Total Operating Expense 531605 501949 438788 409250 329129
Selling/General/Admin. Expenses, Total 23790.5 22101.6 20328.8 18472.1 14761.6
Unusual Expense (Income) 61.683 609.395 133.753 113.698 356.903
Other Operating Expenses, Total -676.163 -589.193 -652.002 -441.164 -373.85
Operating Income 20542.8 19102.6 17626.2 16023 15397.2
Interest Income (Expense), Net Non-Operating -1886.65 -2071.41 -1780.62 -2030.51 -2743.49
Gain (Loss) on Sale of Assets 39.482 64.387 39.384 4.81 15.751
Other, Net -131.801 -92.401 -286.893 -237.537 -461.561
Net Income Before Taxes 18563.8 17003.2 15598.1 13759.8 12207.9
Net Income After Taxes 14345.4 13064.8 12097.3 10620.1 9404.48
Minority Interest -5819.79 -5306.13 -4910.01 -4367.54 -3568.64
Net Income Before Extra. Items 8525.66 7758.65 7187.28 6252.54 5835.84
Net Income 8525.66 7758.65 7187.28 6252.54 5835.84
Income Available to Common Excl. Extra. Items 8525.66 7758.65 7187.2 6251.35 5835.84
Income Available to Common Incl. Extra. Items 8525.66 7758.65 7187.2 6251.35 5835.84
Diluted Net Income 8525.66 7758.65 7187.2 6251.35 5833.55
Diluted Weighted Average Shares 3120.66 3120.66 3111.29 2969.65 2971.66
Diluted EPS Excluding Extraordinary Items 2.73201 2.48622 2.31004 2.10508 1.96306
Dividends per Share - Common Stock Primary Issue 0.79486 0.71052 0.70652 0.58283 0.58928
Diluted Normalized EPS 2.7375 2.62042 2.33356 2.13338 2.0515
Depreciation / Amortization 1779.04 1695.37 1612.97 1413.44 1086.2
Dilution Adjustment -2.295
Interest Expense (Income) - Net Operating 1936.17 1130.82 1273.56 1950.18
Total Adjustments to Net Income -0.074 -1.182
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total revenue 300950 290676 261472 271931 249120
Revenue 300950 290676 261472 271931 249120
Cost of Revenue, Total 277680 264899 239814 248468 228533
Gross Profit 23270.7 25776.6 21657.5 23463.4 20587.2
Total Operating Expense 291365 279197 252407 261612 240336
Selling/General/Admin. Expenses, Total 13691.1 13144.9 12424.7 12039.4 11757.6
Interest Expense (Income) - Net Operating 250.389 1526.66 409.515 829.943 300.878
Unusual Expense (Income) -3.637 69.104 -7.421 621.096 -11.701
Other Operating Expenses, Total -252.209 -442.48 -233.683 -345.899 -243.294
Operating Income 9585.02 11478.4 9064.43 10318.8 8783.73
Interest Income (Expense), Net Non-Operating -736.54 -898.501 -988.144 -1037.71 -1033.7
Gain (Loss) on Sale of Assets 140.156 26.862 12.62 20.34 44.047
Other, Net -122.605 -46.567 -85.234 -15.267 -77.134
Net Income Before Taxes 8866.03 10560.1 8003.67 9286.21 7716.95
Net Income After Taxes 6893.23 8116.82 6228.62 7036.24 6028.53
Minority Interest -2788.79 -3284.91 -2534.87 -2860.44 -2445.69
Net Income Before Extra. Items 4104.44 4831.91 3693.74 4175.81 3582.84
Net Income 4104.44 4831.91 3693.74 4175.81 3582.84
Total Adjustments to Net Income
Income Available to Common Excl. Extra. Items 4104.44 4831.91 3693.74 4175.81 3582.84
Income Available to Common Incl. Extra. Items 4104.44 4831.91 3693.74 4175.81 3582.84
Diluted Net Income 4104.44 4831.91 3693.74 4175.81 3582.84
Diluted Weighted Average Shares 3116.82 3120.66 3120.66 3120.66 3120.66
Diluted EPS Excluding Extraordinary Items 1.31687 1.54836 1.18364 1.33812 1.1481
Dividends per Share - Common Stock Primary Issue 0 0.79486 0 0.71052 0
Diluted Normalized EPS 1.281 1.55877 1.17865 1.48398 1.13415
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 319406 290922 267610 230000 204655
Cash and Short Term Investments 55222.1 43541.2 50217.4 39192.1 40340.2
Cash 55221.6 43529.4 50178.3 39192 40299
Short Term Investments 0.498 11.749 39.141 0.156 41.199
Total Receivables, Net 175733 176273 149448 126563 110364
Accounts Receivable - Trade, Net 153283 159409 134404 109497 96609.7
Total Inventory 60925.8 51499.6 47085.4 42594.4 35388.9
Prepaid Expenses 12288.8 7101.88 8176.93 8794.3 9689.56
Other Current Assets, Total 15236.8 12506.1 12681.8 12855.6 8872.24
Total Assets 364775 335412 311237 269888 235771
Property/Plant/Equipment, Total - Net 19647.2 19407.8 18895.8 18063 11025.1
Property/Plant/Equipment, Total - Gross 34492.5 28241.1 26299.4 24268.1 16207.7
Accumulated Depreciation, Total -14845.3 -8833.35 -7403.56 -6205.03 -5182.61
Goodwill, Net 7155.58 7199.01 7287.39 5664.07 4899.38
Intangibles, Net 3015.34 3192.72 3441.91 3324.78 2577.35
Long Term Investments 10378.8 9772.64 9106.92 8519.99 7648.67
Note Receivable - Long Term 5.862 11.816 33.504 18.288 9.665
Other Long Term Assets, Total 5166.01 4906.24 4861.16 4298.52 4956.3
Total Current Liabilities 234963 219307 203977 178425 160074
Accounts Payable 137085 128431 112632 100334 83682.9
Accrued Expenses 9571.47 8354.29 7760.01 6355.49 5309.51
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 54633.2 56699.7 56365.1 43668.9 50085.2
Other Current Liabilities, Total 33673.2 25821.3 27219.6 28066.5 20996.7
Total Liabilities 296707 273526 254878 222466 192949
Total Long Term Debt 14957 11668.5 12161.7 11470.3 5019.1
Long Term Debt 11750.4 8418.68 8918.73 8372.85 4951.17
Capital Lease Obligations 3206.56 3249.87 3243.01 3097.49 67.934
Deferred Income Tax 936.744 1022.79 1111.74 1099.11 864.906
Minority Interest 42000.6 37767.9 33588.5 29517.2 25453.9
Other Liabilities, Total 3849.25 3760.5 4038.81 1954.93 1536.92
Total Equity 68068.6 61886 56358.8 47422.1 42821.8
Common Stock 3120.66 3120.66 3120.66 2971.66 2971.66
Additional Paid-In Capital 24641.5 24641.5 24641.5 21223.1 21223.1
Retained Earnings (Accumulated Deficit) 40289.2 34103.4 28574 23211.7 18615
Unrealized Gain (Loss) 17.217 20.485 22.655 15.649 12.067
Total Liabilities & Shareholders’ Equity 364775 335412 311237 269888 235771
Total Common Shares Outstanding 3120.66 3120.66 3120.66 2971.66 2971.66
Jun 2023 Dec 2022 Jun 2022 Dec 2021 Jun 2021
Total Current Assets 372155 319406 325263 290922 299953
Cash and Short Term Investments 34377.5 55222.1 32146.4 43541.2 34359.9
Cash 34377.1 55221.6 32146 43529.4 34359.7
Short Term Investments 0.422 0.498 0.347 11.749 0.169
Total Receivables, Net 241477 171204 211754 172576 191112
Accounts Receivable - Trade, Net 229825 153952 201222 159885 182457
Total Inventory 66922.9 60925.8 56992.1 51499.6 50819.7
Prepaid Expenses 18721.9 20016.4 15532.5 13611.3 15489.2
Other Current Assets, Total 10655.2 12038 8838.3 9694.53 8172.28
Total Assets 417692 364775 370180 335412 344331
Property/Plant/Equipment, Total - Net 19655.4 19647.2 19380.7 19407.8 18937.2
Intangibles, Net 10138.7 10170.9 10291.7 10391.7 11006.6
Long Term Investments 10606.6 10378.8 10203 9772.64 9354.3
Note Receivable - Long Term 2.773 5.862 9.887 11.816 28.49
Other Long Term Assets, Total 5133.11 5166.01 5031.51 4906.24 5051.63
Total Current Liabilities 281307 234963 248980 219307 232316
Accounts Payable 156639 137085 131277 128431 121330
Accrued Expenses 35160.7 30889.7 29091.9 26229.8 27755
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 76300.4 54633.2 78161.2 56699.7 73183.7
Other Current Liabilities, Total 13206.3 12355 10450.2 7945.87 10048
Total Liabilities 348087 296707 306939 273526 286542
Total Long Term Debt 18534 14957 13742.5 11668.5 13603.6
Long Term Debt 15225.8 11750.4 10377.7 8418.68 10321
Capital Lease Obligations 3308.25 3206.56 3364.82 3249.87 3282.6
Deferred Income Tax 877.788 936.744 1002.66 1022.79 1073.05
Minority Interest 43506.1 42000.6 39507.1 37767.9 35387.9
Other Liabilities, Total 3862.44 3849.25 3706.84 3760.5 4161.29
Total Equity 69604.5 68068.6 63240.9 61886 57788.8
Common Stock 3120.66 3120.66 3120.66 3120.66 3120.66
Retained Earnings (Accumulated Deficit) 66483.9 64947.9 60120.3 58765.4 54668.2
Total Liabilities & Shareholders’ Equity 417692 364775 370180 335412 344331
Total Common Shares Outstanding 3120.66 3120.66 3120.66 3120.66 3120.66
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 18563.8 17003.2 15598.1 13759.8 12207.9
Cash From Operating Activities 20963.8 9308.08 11154.6 18777.1 3653.74
Cash From Operating Activities 3774.36 3540.39 3207.08 2655.68 1091.22
Amortization 390.661 381.673 390.034 458.396 303.458
Non-Cash Items 4707.74 4558.32 4334.84 4880.49 3483.94
Cash Taxes Paid 4399.09 4074.12 3655.48 3441.27 2767.49
Cash Interest Paid 4777.93 4575.12 4643.62 5180.18 4052.38
Changes in Working Capital -6472.79 -16175.5 -12375.4 -2977.28 -13432.8
Cash From Investing Activities -3589.62 -1266.96 -2202.76 -6795.97 -5907.62
Capital Expenditures -2417.53 -2255.64 -2087.32 -2548.83 -3404.12
Other Investing Cash Flow Items, Total -1172.09 988.68 -115.434 -4247.13 -2503.5
Cash From Financing Activities -5693.48 -14693 2025.85 -13084.6 10318.5
Financing Cash Flow Items -6273.77 -5997.19 -6145.98 -5913.01 -2390.2
Total Cash Dividends Paid -2340.49 -2153.25 -1865.12 -1753.28 -1577.03
Issuance (Retirement) of Debt, Net 2920.78 -6542.56 6436.55 -5468.43 14282.9
Foreign Exchange Effects 11.512 3.047 8.593 -3.582 -6.445
Net Change in Cash 11692.2 -6648.84 10986.3 -1107.02 8058.19
Issuance (Retirement) of Stock, Net 0 3600.4 50.152 2.833
Dec 2022 Jun 2022 Dec 2021 Jun 2021 Dec 2020
Cash From Operating Activities 20963.8 -34293.4 9308.08 -27768.4 11154.6
Cash Taxes Paid 4399.09 2391.25 4074.12 2141.95 3655.48
Cash Interest Paid 4777.93 1847.91 4575.12 1960.69 4643.62
Changes in Working Capital -6472.79 -46872.9 -16175.5 -39610.7 -12375.4
Cash From Investing Activities -3589.62 391.025 -1266.96 88.304 -2202.76
Capital Expenditures -2417.53 -922.7 -2255.64 -852.924 -2087.32
Other Investing Cash Flow Items, Total -1172.09 1313.72 988.68 941.228 -115.434
Cash From Financing Activities -5693.48 22513.6 -14693 11860.4 2025.85
Financing Cash Flow Items -6273.77 -2524.05 -5997.19 -2852.99 -6145.98
Total Cash Dividends Paid -2340.49 -2153.25 0 -1865.12
Issuance (Retirement) of Stock, Net 0 0 3600.4
Issuance (Retirement) of Debt, Net 2920.78 25037.6 -6542.56 14713.4 6436.55
Foreign Exchange Effects 11.512 5.419 3.047 1.097 8.593
Net Change in Cash 11692.2 -11383.4 -6648.84 -15818.5 10986.3
Net income/Starting Line 18563.8 8003.67 17003.2 7716.95 15598.1
Cash From Operating Activities 3774.36 1822.07 3540.39 1708.94 3207.08
Amortization 390.661 178.615 381.673 172.975 390.034
Non-Cash Items 4707.74 2575.15 4558.32 2243.5 4334.84
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Fidelity Management & Research Company LLC Investment Advisor 7.2799 97681813 -1365472 2023-01-27 LOW
Lazard Asset Management, L.L.C. Investment Advisor/Hedge Fund 7.0048 93990820 63855994 2023-04-06 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 4.3607 58512949 -131600 2023-10-03 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 3.2151 43140462 202000 2023-09-30 LOW
Fidelity Institutional Asset Management Investment Advisor 2.272 30486517 6097890 2023-01-27 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.8043 24210000 88800 2023-09-30 LOW
Fidelity Management & Research (Hong Kong) Limited Investment Advisor 1.6285 21850899 0 2023-08-31 LOW
JPMorgan Asset Management (Asia Pacific) Limited Investment Advisor/Hedge Fund 1.5784 21178800 5628400 2023-09-22 MED
Value Partners Ltd. Investment Advisor/Hedge Fund 1.4196 19048000 15200 2023-06-30 MED
BlackRock Asset Management Ireland Limited Investment Advisor 1.3443 18038195 1200 2023-10-03 LOW
Bosera Asset Management Co., Ltd. Investment Advisor 1.2128 16273200 5807200 2023-06-30 MED
State Street Global Advisors Asia Ltd. Investment Advisor/Hedge Fund 1.1219 15054167 15054167 2023-09-30 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.0787 14474301 -15668080 2022-12-31 LOW
Swedbank Robur Fonder AB Investment Advisor/Hedge Fund 1.0543 14146363 0 2023-09-30 LOW
Fidelity Investments Canada ULC Investment Advisor 1.0355 13894800 3232400 2023-01-27 MED
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.9796 13143800 0 2023-09-30 LOW
Federated Hermes International Investment Advisor/Hedge Fund 0.913 12250400 -12672800 2023-06-30 LOW
Florida State Board of Administration Pension Fund 0.7639 10250400 1656800 2022-09-30 LOW
California Public Employees' Retirement System Pension Fund 0.7399 9928548 -250800 2022-06-30 LOW
Nordea Investment Management AB (Denmark) Investment Advisor 0.6471 8682800 16800 2023-09-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Sinopharm Company profile

About SINOPHARM HOLDING CO LTD

Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, SINOPHARM HOLDING CO LTD revenues increased 14% to RMB521.05B. Net income applicable to common stockholders increased 8% to RMB7.76B. Revenues reflect Retail Sales - Total increase of 20% to RMB28.57B. Net income was partially offset by Impairment of Intangibles increase from RMB265M to RMB606.9M (expense), Bank and other borrowings increase of 10% to RMB2.87B (expense).

Industry: Pharmaceuticals Wholesale

黄浦区龙华东路385号12层
SHANGHAI
SHANGHAI 200023
CN

Income Statement

  • Annual
  • Quarterly

News

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023
GBP

UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

10:48, 21 November 2023

People also watch

Oil - Crude

73.79 Price
-1.040% 1D Chg, %
Long position overnight fee -0.0136%
Short position overnight fee -0.0083%
Overnight fee time 22:00 (UTC)
Spread 0.030

US100

15,939.70 Price
-0.350% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 22:00 (UTC)
Spread 1.8

Gold

2,086.52 Price
+0.630% 1D Chg, %
Long position overnight fee -0.0193%
Short position overnight fee 0.0111%
Overnight fee time 22:00 (UTC)
Spread 0.30

XRP/USD

0.63 Price
+1.360% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading